Literature DB >> 4198103

Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.

R G Neiburger, G P Youmans, A S Youmans.   

Abstract

The migration inhibition technique has been used to study delayed hypersensitivity in vitro by using peritoneal exudate cells and splenic lymphocytes from mice vaccinated with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis and from mice vaccinated with ribonucleic acid (myc RNA) preparations obtained from viable mycobacterial cells of the same strain. Inhibition of macrophage migration was noted when purified protein derivative (PPD) or viable H37Ra cells were added to peritoneal exudate cells obtained from mice immunized with viable H37Ra cells and not from mice immunized with myc RNA. Splenic lymphocyte cultures were exposed to the same antigens in vitro. Filtered supernatant fluids from these lymphocyte cultures, when added to peritoneal exudate cells obtained from nonimmunized mice, inhibited migration only when they were obtained from lymphocytes which came from mice immunized with viable H37Ra cells. Injection of PPD intravenously into vaccinated mice resulted in inhibitory supernatant fluids from splenic lymphocyte cultures only when the lymphocytes came from mice immunized with viable H37Ra cells. However, intravenous injection of either viable H37Ra cells or of myc RNA preparations into mice vaccinated with myc RNA occasionally produced inhibitory supernatant fluids when lymphocytes were obtained from these mice. On the other hand, mice vaccinated with myc RNA or viable H37Ra cell preparations were consistently and equally protected against intravenous challenge with the virulent H37Rv strain. Thus, although some evidence was obtained for a delayed type hypersensitivity in mice vaccinated with H37Ra cells or with myc RNA to ribosomal proteins or other proteins associated with the RNA preparation, no evidence of tuberculin hypersensitivity could be detected in any mice vaccinated with the myc RNA. These results argue against a role for tuberculin hypersensitivity in immunity to tuberculous infection.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4198103      PMCID: PMC422807          DOI: 10.1128/iai.8.1.42-47.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

Review 2.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

3.  Delayed hypersensitivity to ribosomal protein from BCG.

Authors:  L Ortiz-Ortiz; E B Solarolo; L F Bojalil
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

4.  Recent studies on acquired immunity in tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

5.  Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

6.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

7.  Nonspecific factors in resistance of mice to experimental tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

8.  Delayed hypersensitivity reactions provoked by ribosomes from acid-fast bacilli. I. Ribosomal isolation, characterization, delayed hypersensitivity, and specificity.

Authors:  R E Baker; W E Hill; C L Larson
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.

Authors:  S Coppel; G P Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  15 in total

1.  Subcellular localisation and sedimentation behaviour of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

Review 2.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

3.  Delayed-type hypersensitivity and immunity against aerogenic tuberculosis in guinea pigs.

Authors:  Z Reggiardo; G Middlebrook
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

Review 4.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

5.  Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Authors:  I I Andron LA; H T Eigelsbach
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

6.  Regulation of the immune response by macrophages.

Authors:  J M Willers; N Bloksma; C van der Meer; H Snippe; H van Dijk; M J de Reuver; F M Hofhuis
Journal:  Antonie Van Leeuwenhoek       Date:  1979       Impact factor: 2.271

7.  Delayed dermal hypersensitivity in rhesus monkeys (Macaca mulatta) immunized against Plasmodium knowlesi.

Authors:  E J Cabrera; C A Speer; R H Schenkel; M L Barr; P H Silverman
Journal:  Z Parasitenkd       Date:  1976-07-27

8.  Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.

Authors:  S C Agarwal; T Sundararaj
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

9.  Delayed hypersensitivity and acquired cellular resistance in guinea pigs infected with Listeria monocytogenes.

Authors:  B L Halliburton; A A Blazkovec
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

10.  Preparation and properties of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.